(Q37736540)

22 August 2017

1 reference

title

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

22 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

2

Jannis Kountouras

1 reference

22 August 2017

Stergios A Polyzos

1

1 reference

22 August 2017

Christos Zavos

series ordinal

3

1 reference

22 August 2017

Eleni Tsiaousi

series ordinal

4

1 reference

22 August 2017

language of work or name

1 reference

1 May 2010

1 reference

Diabetes, Obesity and Metabolism

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

365-383

1 reference

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Food for thought: endocannabinoid modulation of lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01176.X

10.1111/J.1463-1326.2009.01176.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference